Instantaneous mutation rate in cancer initiation and progression

Shuhao Sun, Fima C Klebaner, Xinan Zhang, Tianhai Tian

Research output: Contribution to journalArticleResearchpeer-review

Abstract

BACKGROUND: Cancer is one of the leading causes for the morbidity and mortality worldwide. Although substantial studies have been conducted theoretically and experimentally in recent years, it is still a challenge to explore the mechanisms of cancer initiation and progression. The investigation for these problems is very important for the diagnosis of cancer diseases and development of treatment schemes. RESULTS: To accurately describe the process of cancer initiation, we propose a new concept of gene initial mutation rate based on our recently designed mathematical model using the non-constant mutation rate. Unlike the widely-used average gene mutation rate that depends on the number of mutations, the gene initial mutation rate can be used to describe the initiation process of a single patient. In addition, we propose the instantaneous tumour doubling time that is a continuous function of time based on the non-constant mutation rate. Our proposed concepts are supported by the clinic data of seven patients with advanced pancreatic cancer. The regression results suggest that, compared with the average mutation rate, the estimated initial mutation rate has a larger value of correlation coefficient with the patient survival time. We also provide the estimated tumour size of these seven patients over time. CONCLUSIONS: The proposed concepts can be used to describe the cancer initiation and progression for different patients more accurately. Since a quantitative understanding of cancer progression is important for clinical treatment, our proposed model and calculated results may provide insights into the development of treatment schemes and also have other clinic implications.

Original languageEnglish
Pages (from-to)91-98
Number of pages8
JournalBMC Systems Biology
Volume12
Issue numberSuppl 6
DOIs
Publication statusPublished - 22 Nov 2018

Keywords

  • Cancer
  • Mathematical model
  • Initial mutation rate
  • Cancer cell doubling time

Cite this

@article{e8c860d620e84a2dadfd5d8e37d594ae,
title = "Instantaneous mutation rate in cancer initiation and progression",
abstract = "BACKGROUND: Cancer is one of the leading causes for the morbidity and mortality worldwide. Although substantial studies have been conducted theoretically and experimentally in recent years, it is still a challenge to explore the mechanisms of cancer initiation and progression. The investigation for these problems is very important for the diagnosis of cancer diseases and development of treatment schemes. RESULTS: To accurately describe the process of cancer initiation, we propose a new concept of gene initial mutation rate based on our recently designed mathematical model using the non-constant mutation rate. Unlike the widely-used average gene mutation rate that depends on the number of mutations, the gene initial mutation rate can be used to describe the initiation process of a single patient. In addition, we propose the instantaneous tumour doubling time that is a continuous function of time based on the non-constant mutation rate. Our proposed concepts are supported by the clinic data of seven patients with advanced pancreatic cancer. The regression results suggest that, compared with the average mutation rate, the estimated initial mutation rate has a larger value of correlation coefficient with the patient survival time. We also provide the estimated tumour size of these seven patients over time. CONCLUSIONS: The proposed concepts can be used to describe the cancer initiation and progression for different patients more accurately. Since a quantitative understanding of cancer progression is important for clinical treatment, our proposed model and calculated results may provide insights into the development of treatment schemes and also have other clinic implications.",
keywords = "Cancer, Mathematical model, Initial mutation rate, Cancer cell doubling time",
author = "Shuhao Sun and Klebaner, {Fima C} and Xinan Zhang and Tianhai Tian",
year = "2018",
month = "11",
day = "22",
doi = "10.1186/s12918-018-0629-z",
language = "English",
volume = "12",
pages = "91--98",
journal = "BMC Systems Biology",
issn = "1752-0509",
publisher = "Springer-Verlag London Ltd.",
number = "Suppl 6",

}

Instantaneous mutation rate in cancer initiation and progression. / Sun, Shuhao; Klebaner, Fima C; Zhang, Xinan; Tian, Tianhai.

In: BMC Systems Biology, Vol. 12, No. Suppl 6, 22.11.2018, p. 91-98.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Instantaneous mutation rate in cancer initiation and progression

AU - Sun, Shuhao

AU - Klebaner, Fima C

AU - Zhang, Xinan

AU - Tian, Tianhai

PY - 2018/11/22

Y1 - 2018/11/22

N2 - BACKGROUND: Cancer is one of the leading causes for the morbidity and mortality worldwide. Although substantial studies have been conducted theoretically and experimentally in recent years, it is still a challenge to explore the mechanisms of cancer initiation and progression. The investigation for these problems is very important for the diagnosis of cancer diseases and development of treatment schemes. RESULTS: To accurately describe the process of cancer initiation, we propose a new concept of gene initial mutation rate based on our recently designed mathematical model using the non-constant mutation rate. Unlike the widely-used average gene mutation rate that depends on the number of mutations, the gene initial mutation rate can be used to describe the initiation process of a single patient. In addition, we propose the instantaneous tumour doubling time that is a continuous function of time based on the non-constant mutation rate. Our proposed concepts are supported by the clinic data of seven patients with advanced pancreatic cancer. The regression results suggest that, compared with the average mutation rate, the estimated initial mutation rate has a larger value of correlation coefficient with the patient survival time. We also provide the estimated tumour size of these seven patients over time. CONCLUSIONS: The proposed concepts can be used to describe the cancer initiation and progression for different patients more accurately. Since a quantitative understanding of cancer progression is important for clinical treatment, our proposed model and calculated results may provide insights into the development of treatment schemes and also have other clinic implications.

AB - BACKGROUND: Cancer is one of the leading causes for the morbidity and mortality worldwide. Although substantial studies have been conducted theoretically and experimentally in recent years, it is still a challenge to explore the mechanisms of cancer initiation and progression. The investigation for these problems is very important for the diagnosis of cancer diseases and development of treatment schemes. RESULTS: To accurately describe the process of cancer initiation, we propose a new concept of gene initial mutation rate based on our recently designed mathematical model using the non-constant mutation rate. Unlike the widely-used average gene mutation rate that depends on the number of mutations, the gene initial mutation rate can be used to describe the initiation process of a single patient. In addition, we propose the instantaneous tumour doubling time that is a continuous function of time based on the non-constant mutation rate. Our proposed concepts are supported by the clinic data of seven patients with advanced pancreatic cancer. The regression results suggest that, compared with the average mutation rate, the estimated initial mutation rate has a larger value of correlation coefficient with the patient survival time. We also provide the estimated tumour size of these seven patients over time. CONCLUSIONS: The proposed concepts can be used to describe the cancer initiation and progression for different patients more accurately. Since a quantitative understanding of cancer progression is important for clinical treatment, our proposed model and calculated results may provide insights into the development of treatment schemes and also have other clinic implications.

KW - Cancer

KW - Mathematical model

KW - Initial mutation rate

KW - Cancer cell doubling time

UR - http://www.scopus.com/inward/record.url?scp=85056913056&partnerID=8YFLogxK

U2 - 10.1186/s12918-018-0629-z

DO - 10.1186/s12918-018-0629-z

M3 - Article

VL - 12

SP - 91

EP - 98

JO - BMC Systems Biology

JF - BMC Systems Biology

SN - 1752-0509

IS - Suppl 6

ER -